Connected at the Core

Hemanth is an accomplished healthcare executive with a 20-year track record of performance and execution. He is a versatile leader with experience leading diverse healthcare businesses in high-growth markets in North America and internationally, managing complex business transformations and high-growth corporate strategy initiatives, executing transformational M&A and driving critical business development activities

Before joining Venus Concept, Dr. Varghese served as Senior Vice President of Strategy & Operations at HLS Therapeutics from 2017 to 2022. He previously worked for Endo International Plc, a multinational healthcare company, from 2014 to 2017 as President of International Pharmaceuticals and Executive Vice President of Corporate Development & Strategy. From 2009 to 2014, Dr. Varghese served as General Manager of Vision Care at Bausch & Lomb and Senior Vice President of Corporate Development at Valeant Pharmaceuticals (now Bausch Health). He has also held leadership roles in venture capital and corporate development enterprises with a specialization in healthcare technology, medical devices, and imaging modalities. Dr. Varghese has an Honors BSc and a PhD in Medical Biophysics from Western University and is a CFA charter holder.

Domenic brings considerable expertise and experience to Venus Concept, having held senior posts at several industry leading multinationals like Teva Pharmaceuticals, Diageo and Nestle. Most recently, he was CFO of Intellipharmaceutics International Inc. —a Nasdaq and TSX listed public company. Domenic also secured private equity experience through a successful mandate as CFO of Timothy’s Coffees of The World. He has made significant contributions to numerous mergers, acquisitions, divestitures, financial systems, and organizational change mandates. Domenic is a C.A., CPA, and holds an MBA from the Schulich School of Business at York University (Toronto).

Ross is an accomplished industry leader and veteran, bringing over 30 years of experience in the healthcare sector to Venus Concept. His vast experience as a leader in sales includes positions at Candela Medical, Lumenis, and Ulthera, Inc. 

Ross holds a B.S. in Commerce from the University of Virginia’s McIntire School of Commerce.

Anna brings over 20 years of experience in HR and business roles. Prior to joining Venus Concept, Anna was at Loblaw Companies Limited, a leading food and pharmacy leader in Canada, and her contributions extended to Human Resources, Training, Internal Communications, Sales Enablement as well as P&L responsibilities for various business units.

Bill has more than 25 years’ experience in the medical device industry. His extensive experience is in new product development as well as regulatory affairs and quality assurance for product clearance and distribution in the U.S., European Union, Canada and a number of other foreign markets. His expertise includes detailed product development process execution, regulatory strategy, implementation and compliance, quality design control process adherence and management representative responsibilities. 

Prior to joining Venus Concept, Bill served as Vice President of Quality and Regulatory Assurance at InfoBionic Inc., where he was responsible for quality and regulatory clearances of wireless heart arrhythmia monitors connected to a cloud-based platform. As Vice President of R&D for AgaMatrix, Inc., he was responsible for the design and development of state-of-the-art blood glucose meters. As Vice President of Regulatory, Quality and Clinical, he was responsible for the worldwide clearance of blood glucose meters and fully integrated mobile health manager applications. As Vice President of R&D, Regulatory and Quality for Eleme Medical, Inc., Bill was responsible for new product development, regulatory and quality compliance for aesthetic diode laser systems for dermatology and plastic surgery. Bill spent 20 years at Candela Corporation where he held a number of executive level positions. As Senior Vice President of Operations, he was responsible for new product development, regulatory and quality compliance and manufacture of a variety of aesthetic medical laser systems. 

Bill holds a BSEE from the University of Lowell (now UMass Lowell) and an MBA from Boston University. 

Michael brings more than 10 years of experience providing legal and strategic advice to Venus Concept.

Michael began his legal career in 2011 with Osler, Hoskin & Harcourt LLP, one of the top law firms in Canada, in its Corporate Law group. He continued to practice business law in progressive in-house roles at the Toronto Organizing Committee for the 2015 Pan-Am Games, and then with Walmart Canada Corp. prior to joining Venus Concept. 

Michael earned his Juris Doctor from the University of Windsor, Faculty of Law in 2010, graduating in the top 5th percentile of his class. He also holds an Honors Bachelor of Arts Degree from the University of Toronto, graduating with High Distinction in 2007. Michael was called to the Bar of Ontario in 2011.

Rajiv brings extensive executive experience and expertise in the fields of dermatology, aesthetics, pharmaceuticals, medical devices and healthcare. He currently serves as the Chairman of the Board of Directors of Covis Pharma, a multinational specialty pharmaceutical company, and is a co-founder of Asiri Skincare, a privately held company focused on topical consumer therapeutic skincare products. He has previously served as President, Chief Executive Officer, and Director of Endo International Plc, a publicly traded, multinational pharmaceutical corporation, as well as President of Valeant Pharmaceuticals International (now Bausch Health), where he also served as Chief Operating Officer of the company’s Specialty Pharmaceuticals business, including its dermatology and aesthetics unit. Prior to that, Rajiv held various leadership positions within Novartis AG, including President of Novartis Pharma Canada. Rajiv began his career in healthcare at McKinsey & Company in 1995, where he rose to Partner. 

Rajiv holds a Bachelor of Science in Engineering with Honors from Princeton University, a Master of Science from Stanford University, and a Master of Business Administration with Distinction from the Wharton School of the University of Pennsylvania.